» Articles » PMID: 20448202

Zinc Ions Promote Alzheimer Abeta Aggregation Via Population Shift of Polymorphic States

Overview
Specialty Science
Date 2010 May 8
PMID 20448202
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

Although a key factor in Alzheimer's disease etiology is enrichment of Zn(2+) in aggregates, and there are data suggesting that zinc promotes aggregation, how Zn(2+)-Abeta coordination promotes aggregation is elusive. Here we probe the structures and mechanisms through which Zn(2+) can affect amyloidosis. By covalently linking fragments (that have experiment-based coordinates) we observed that, in oligomeric Zn(2+)-Abeta(42), Zn(2+) can simultaneously coordinate intra- and intermolecularly, bridging two peptides. Zinc coordination significantly decreases the solvation energy for large Zn(2+)-Abeta(42) oligomers and thus enhances their aggregation tendency. Zn(2+) binding does not change the beta-sheet association around the C-terminal hydrophobic region; however, it shifts the relative population of the preexisting amyloid polymorphic ensembles. As a result, although a parallel beta-sheet arrangement is still preferred, antiparallel and other less structured assemblies are stabilized, also becoming major species. Overall, Zn(2+) coordination promotes Abeta(42) aggregation leading to less uniform structures. Our replica exchange molecular dynamics simulations further reproduced an experimental observation that the increasing Zn(2+) concentration could slow down the aggregation rate, even though the aggregation rates are still much higher than in Zn(2+)-free solution.

Citing Articles

Zn(ii)-driven impact of monomeric transthyretin on amyloid-β amyloidogenesis.

Yi Y, Kim B, Kim M, Ko Y, Kim J, Lim M Chem Sci. 2025; 16(10):4366-4373.

PMID: 39911331 PMC: 11793109. DOI: 10.1039/d4sc08771b.


Survey of the Aβ-peptide structural diversity: molecular dynamics approaches.

Tolstova A, Adzhubei A, Strelkova M, Makarov A, Mitkevich V Biophys Rev. 2025; 16(6):701-722.

PMID: 39830132 PMC: 11735825. DOI: 10.1007/s12551-024-01253-y.


Alterations in zinc, copper, and iron levels in the retina and brain of Alzheimer's disease patients and the APP/PS1 mouse model.

Hosseinpour Mashkani S, Bishop D, Westerhausen M, Adlard P, Golzan S Metallomics. 2024; 16(12).

PMID: 39520546 PMC: 11630249. DOI: 10.1093/mtomcs/mfae053.


The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer's Disease Etiopathology.

Fanlo-Ucar H, Picon-Pages P, Herrera-Fernandez V, Ill-Raga G, Munoz F Antioxidants (Basel). 2024; 13(10).

PMID: 39456461 PMC: 11505517. DOI: 10.3390/antiox13101208.


Preparation and Characterization of Zn(II)-Stabilized Aβ Oligomers.

Gonzalez Diaz A, Cataldi R, Mannini B, Vendruscolo M ACS Chem Neurosci. 2024; 15(14):2586-2599.

PMID: 38979921 PMC: 11258685. DOI: 10.1021/acschemneuro.4c00084.


References
1.
Noy D, Solomonov I, Sinkevich O, Arad T, Kjaer K, Sagi I . Zinc-amyloid beta interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species. J Am Chem Soc. 2008; 130(4):1376-83. DOI: 10.1021/ja076282l. View

2.
Miller Y, Ma B, Nussinov R . Polymorphism of Alzheimer's Abeta17-42 (p3) oligomers: the importance of the turn location and its conformation. Biophys J. 2009; 97(4):1168-77. PMC: 2726324. DOI: 10.1016/j.bpj.2009.05.042. View

3.
Jiao Y, Yang P . Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation. J Phys Chem B. 2007; 111(26):7646-55. DOI: 10.1021/jp0673359. View

4.
Minicozzi V, Stellato F, Comai M, Serra M, Potrich C, Meyer-Klaucke W . Identifying the minimal copper- and zinc-binding site sequence in amyloid-beta peptides. J Biol Chem. 2008; 283(16):10784-92. DOI: 10.1074/jbc.M707109200. View

5.
Kumar S, Ma B, Tsai C, Sinha N, Nussinov R . Folding and binding cascades: dynamic landscapes and population shifts. Protein Sci. 2000; 9(1):10-9. PMC: 2144430. DOI: 10.1110/ps.9.1.10. View